POT1 clinical risk management is an open question

Eur J Hum Genet. 2025 Jan;33(1):3-4. doi: 10.1038/s41431-024-01676-x. Epub 2024 Aug 13.

Mandy L Ballinger^{1

2

3}, David M Thomas^{4

5

6}

¹ Genomic Cancer Medicine Laboratory, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. [email protected].
² Centre for Molecular Oncology, Faculty of Medicine, University of New South Wales, Kensington, NSW, Australia. [email protected].
³ Omico, Kensington, NSW, Australia. [email protected].
⁴ Genomic Cancer Medicine Laboratory, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
⁵ Centre for Molecular Oncology, Faculty of Medicine, University of New South Wales, Kensington, NSW, Australia.
⁶ Omico, Kensington, NSW, Australia.

No abstract available

Publication types